SCHEMBL8892973

SCHEMBL8892973

CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NC(=O)N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 4/20 0.52
CTSL P07711 3/20 0.50
CTSB P07858 3/20 0.49
PSMB11 A5LHX3 2/20 0.47
PSMA7 O14818 2/20 0.47
PSMB1 P20618 2/20 0.47
PSMA1 P25786 2/20 0.47
PSMA2 P25787 2/20 0.47
PSMA3 P25788 2/20 0.47
PSMA4 P25789 2/20 0.47
PSMB8 P28062 2/20 0.47
PSMB9 P28065 2/20 0.47
PSMA5 P28066 2/20 0.47
PSMB4 P28070 2/20 0.47
PSMB6 P28072 2/20 0.47
PSMB5 P28074 2/20 0.47
PSMB10 P40306 2/20 0.47
PSMB3 P49720 2/20 0.47
PSMB2 P49721 2/20 0.47
PSMA6 P60900 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8894828 0.92 CTSL (0.48) CTSSCTSLCTSBPSMB11PSMA7
SCHEMBL6429766 0.87 CTSS (0.52) CTSSCTSLCTSBPSMB11PSMA7
SCHEMBL8894263 0.86 CTSS (0.47) CTSSCTSLCTSBPSMB11PSMA7
SCHEMBL7388307 0.85 CTSK (0.51) CTSSCTSLCTSB
SCHEMBL7514990 0.84 CTSS (0.51) CTSSCTSLCTSBPSMB5
SCHEMBL4311269 0.83 MMP8 (0.56) CTSSCTSLCTSBTACR2MMP8
SCHEMBL7404833 0.83 MMP8 (0.56) CTSSCTSLCTSBTACR2MMP8
SCHEMBL8893516 0.82 CASP3 (0.51) CTSSCTSLCTSB
SCHEMBL29350741 0.79 FNTA (0.56)
SCHEMBL8895445 0.78 CTSB (0.47) CTSSCTSLCTSBPSMB11PSMA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5643878-A TREATMENT OF RETROVIRAL DISEASES LIKE AIDS CIBA-GEIGY CORPORATION (US) 1997-07-01 US disclosed
EP-0626178-A1 Use of inhibitors of HIV-protease for the treatment of tumorous diseases CIBA-GEIGY AG (CH) 1994-11-30 EP disclosed